Spots Global Cancer Trial Database for An Extension Study for Patients Previously Treated With ARQ 501
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: An Extension Study for Patients Previously Treated With ARQ 501
Official Title: An Extension Study for Patients Previously Treated With ARQ 501
Study ID: NCT00622063
Conditions
Interventions
Study Description
Brief Summary: To provide ongoing treatment with ARQ 501 for patients who have benefited from prior treatment with ARQ 501
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Mary Crowley Medical Research Center, Dallas, Texas, United States
Contact Details
Name: Neil Nathan Senzer, MD
Affiliation: Mary Crowley Medical Research Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
